Halozyme Therapeutics
HALO
#2375
Rank
$6.65 B
Marketcap
$53.98
Share price
-1.03%
Change (1 day)
8.70%
Change (1 year)

Halozyme Therapeutics (HALO) - Total debt

Total debt on the balance sheet as of March 2025 : $1.50 Billion USD

According to Halozyme Therapeutics's latest financial reports the company's total debt is $1.50 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Halozyme Therapeutics - Total debt on balance sheet (from 2011 to 2025)

Total debt by year

Year Total debt Change
2024-12-31$1.50 B0.44%
2023-12-31$1.49 B-0.45%
2022-12-31$1.50 B71.8%
2021-12-31$0.87 B120.7%
2020-12-31$0.39 B-1.33%
2019-12-31$0.40 B218.55%
2018-12-31$0.12 B-37.54%
2017-12-31$0.20 B-6.59%
2016-12-31$0.21 B334.69%
2015-12-31$49.83 M-0.05%
2014-12-31$49.86 M0.18%
2013-12-31$49.77 M59.98%
2012-12-31$31.11 M
2011-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
MannKind Corp
MNKD
$47.25 M-96.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$38.51 B 2,455.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
$10.30 B 583.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$61.29 B 3,965.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$22.78 B 1,411.23%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
$52.25 B 3,366.25%๐Ÿ‡บ๐Ÿ‡ธ USA